Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2020-01-27 2019-01-23
Drug Identification Number 02246414 02246414
Brand name AVELOX I.V. AVELOX I.V.
Common or Proper name Moxifloxacin Injection Moxifloxacin Injection
Company Name BAYER INC BAYER INC
Ingredients MOXIFLOXACIN MOXIFLOXACIN
Strength(s) 400MG 400MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250 mL 250 mL
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-02-28 2019-12-31
Actual discontinuation date
Remaining supply date 2020-02-28 2019-12-31
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments